Grufity logoGrufity logo

MASI

145.74USD+0.80(+0.55%)Market Closed

Masimo Corp

Market Summary

USD145.74+0.80Market Closed
0.55%

MASI Alerts

MASI Stock Price

RSI Chart

Valuation

Market Cap

7.0B

Price/Earnings

36.89

Price/Sales

4.68

Price/Cashflow

34.3

MarketCap/EBT

30.6

Price/Sales

Profitability

EBT Margin

15.29%

Return on Equity

15.86%

Return on Assets

6.44%

Fundamentals

Revenue

Revenue (TTM)

1.7B

Revenue Y/Y

78.68%

Revenue Q/Q

-2.83%

Earnings

Earnings (TTM)

190.7M

Earnings Y/Y

-63.97%

Earnings Q/Q

-61.16%

Price Action

52 Week Range

299.78
(Low)(High)

Last 7 days

1.3%

Last 30 days

10.1%

Last 90 days

-0.8%

Trailing 12 Months

-47.9%

Financial Health

Current Ratio

2.1

Debt/Equity

0.78

Debt/Cashflow

0.22

Investor Care

Buy Backs (1Y)

4.75%

Diluted EPS (TTM)

3.02

Peers (Alternatives to Masimo)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
115.4B
31.1B
-9.50% -24.43%
22.17
3.71
-1.67% 34.08%
86.3B
6.1B
9.71% -16.63%
62.6
14.1
11.47% -18.42%
43.9B
5.4B
6.65% -28.01%
30.09
8.18
5.29% -1.25%
16.7B
4.9B
12.33% 1.91%
11.05
3.2
-13.66% -30.36%
14.7B
3.9B
1.21% -67.84%
23.8
3.69
2.88% -30.98%
MID-CAP
6.4B
806.4M
22.18% -14.71%
-331.15
7.96
20.10% -221.96%
5.4B
2.5B
3.36% -12.06%
21.1
2.14
-7.05% -15.83%
2.5B
1.0B
17.56% -30.93%
-91.07
2.5
-1.73% 77.34%
2.4B
1.1B
3.91% -36.88%
-29.5
2.28
7.99% -232.91%
SMALL-CAP
1.4B
153.2M
13.07% -1.21%
-19.11
9.54
29.47% -132.69%
1.4B
71.8M
28.31% 180.72%
-28.63
26.58
154.25% -11.51%
1.0B
795.9M
21.44% -10.84%
-131.34
1.33
8.11% 182.50%
994.0M
154.8M
-9.99% -44.52%
-10.57
6.72
60.29% -2309.58%
516.6M
353.3M
-1.50% -26.94%
-18.21
1.46
4.89% -1057.51%
86.7M
510.5M
-15.55% -80.19%
-0.87
0.16
-26.64% -46.15%

Financials for Masimo

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue16.1%1,7461,5051,2441,2391,207
Gross Profit8.9%960882816808780
Operating Expenses14.0%746655546533517
  S&GA Expenses14.7%576502408395382
  R&D Expenses11.6%170153139137136
Earnings Before Taxes-6.8%214230269274264
Net Income-14.4%191223230232
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets3.2%3,0562,9611,9091,8871,767
  Current Assets7.5%1,2461,1581,2251,2381,138
    Cash Equivalents0.7%220218720745652
  Inventory10.3%495449213201202
  Net PPE0.4%372371300273275
  Goodwill2.7%44643599100101
Liabilities2.6%1,8041,758327337299
  Current Liabilities6.4%587552254268228
  Long Term Debt3.1%965936---
    LT Debt, Non Current3.1%951922---
Shareholder's Equity4.1%1,2531,2031,5821,5501,468
  Retained Earnings2.3%1,6741,6361,6171,5711,503
  Additional Paid-In Capital2.1%775759741753737
Accumulated Depreciation-158----
Shares Outstanding0.2%5353565555
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-34.9%134205229265232
  Share Based Compensation1.7%5352434539
Cashflow From Investing0.6%-1,040.96-1,047.53-50.84-37.53-33.41
Cashflow From Financing3.8%529510-4.78-122.40-219.93
  Buy Backs0%4014010129239
* denotes actual numbers (not divided by Millions)

Risks

What is the probability of a big loss on MASI?

41.1%


Probability that Masimo stock will be more than 20% underwater in next one year

16.9%


Probability that Masimo stock will be more than 30% underwater in next one year.

15.8%


Probability that Masimo stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Masimo was unfortunately bought at previous high price.

Returns

Cumulative Returns on MASI

21.5%


10-Year Cumulative Returns

19.6%


7-Year Cumulative Returns

10.3%


5-Year Cumulative Returns

-2.2%


3-Year Cumulative Returns

What are the long-term rolling returns for MASI?

FIve years rolling returns for Masimo.

Which funds bought or sold MASI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
Capital Impact Advisors, LLC
REDUCED
-36.64
-112,000
242,000
0.24%
2022-11-22
CVA Family Office, LLC
UNCHANGED
-
-
3,000
-%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
1,093,000
1,093,000
0.01%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
REDUCED
-1.94
680,000
12,141,000
0.02%
2022-11-18
National Pension Service
UNCHANGED
-
-
1,000
-%
2022-11-17
CENTRAL TRUST Co
UNCHANGED
-
2,000
28,000
-%
2022-11-17
M&T Bank Corp
ADDED
1.55
26,000
259,000
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
ADDED
33.11
69,000
226,000
-%
2022-11-16
Retirement Systems of Alabama
REDUCED
-2.56
1,077,000
21,523,000
0.10%
2022-11-15
JACOBS LEVY EQUITY MANAGEMENT, INC
REDUCED
-77.62
-11,004,000
3,510,000
0.03%

1–10 of 44

Latest Funds Activity

Are funds buying MASI calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own MASI

Masimo News

Simply Wall St

Has Masimo Corporation's (NASDAQ:MASI) Impressive Stock Performance Got Anything to Do With Its Fundamentals?.12 hours ago

MASI Fair Value

Recent SEC filings of Masimo

View All Filings
Date Filed Form Type Document
Nov 15, 2022
4
Insider Trading
Nov 15, 2022
4
Insider Trading
Nov 09, 2022
10-Q
Quarterly Report
Nov 08, 2022
8-K
Current Report
Oct 21, 2022
SC 13D/A
13D - Major Acquisition
Sep 27, 2022
SC 13D/A
13D - Major Acquisition
Sep 26, 2022
3
Insider Trading
Sep 19, 2022
8-K
Current Report
Sep 09, 2022
8-A12B
8-A12B
Sep 09, 2022
8-K
Current Report

Latest Insider Trading transactions for MASI

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-14
KIANI JOE E
BOUGHT
3,967,010
123.992
31,994
CEO and Chairman of the Board
2022-11-11
KIANI JOE E
BOUGHT
1,006,250
129.272
7,784
CEO and Chairman of the Board
2022-05-26
REYNOLDS CRAIG B
ACQUIRED
128,471
139.34
922
-
2022-05-26
Cohen H Michael
ACQUIRED
128,471
139.34
922
-
2022-05-26
Shimer Julie Ann
ACQUIRED
128,471
139.34
922
-
2022-05-26
Mikkelson Adam
ACQUIRED
128,471
139.34
922
-
2022-02-14
KIANI JOE E
ACQUIRED
-
-
93,032
CEO and Chairman of the Board
2022-02-14
Young Micah W
ACQUIRED
-
-
9,302
EVP & Chief Financial Officer
2022-02-14
Levy Tao
ACQUIRED
-
-
9,302
EVP, Bus Dev
2022-02-14
Muhsin Bilal
ACQUIRED
-
-
9,302
Chief Operating Officer

1–10 of 50

Joe E. Kiani
6200
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.

MASI Income Statement

2022-10-01
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Oct. 01, 2022
Oct. 02, 2021
Income Statement [Abstract]    
Revenue$ 549.3$ 307.4$ 1,418.8$ 911.6
Cost of goods sold266.8103.8673.4318.1
Gross profit282.5203.6745.4593.5
Selling, general and administrative174.6100.6471.6291.2
Research and development53.135.4137.1103.9
Total operating expenses227.7136.0608.7395.1
Operating income54.867.6136.7198.4
Non-operating (loss) income(2.8)0.01.0(0.7)
Income before provision for income taxes52.067.6137.7197.7
Provision for income taxes14.19.835.136.3
Net income$ 37.9$ 57.8$ 102.6$ 161.4
Net income per share:    
Basic (in dollars per share)$ 0.72$ 1.05$ 1.90$ 2.93
Diluted (in dollars per share)$ 0.70$ 1.00$ 1.85$ 2.80
Weighted-average shares used in per share calculations:    
Basic (in shares)52.555.154.055.1
Diluted (in shares)54.157.755.657.7

MASI Balance Sheet

2022-10-01
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Oct. 01, 2022
Jan. 01, 2022
Current assets  
Cash and cash equivalents$ 219.5$ 745.3
Trade accounts receivable, net of allowance for credit losses of $3.8 million and $2.2 million at October 1, 2022 and January 1, 2022, respectively371.6200.8
Inventories495.4201.4
Other current assets159.191.0
Total current assets1,245.61,238.5
Lease receivable, noncurrent79.673.6
Deferred costs and other contract assets37.028.1
Property and equipment, net372.2272.8
Intangible assets, net446.672.5
Trademarks - (Note 9)262.00.0
Goodwill446.3100.3
Deferred tax assets56.552.6
Other non-current assets110.648.6
Total assets3,056.41,887.0
Current liabilities  
Accounts payable267.875.5
Accrued compensation90.470.8
Deferred revenue and other contract liabilities, current77.650.9
Other current liabilities151.570.4
Total current liabilities587.3267.6
Long-term debt951.40.0
Deferred tax liabilities139.25.1
Other non-current liabilities125.964.0
Total liabilities1,803.8336.7
Commitments and contingencies - (Note 24)
Stockholders’ equity  
Preferred stock, $0.001 par value; 5.0 million shares authorized; 0 shares issued and outstanding0.00.0
Common stock, $0.001 par value; 100.0 million shares authorized; 52.6 million and 55.3 million shares issued and outstanding at October 1, 2022 and January 1, 2022, respectively0.10.1
Treasury stock, 19.5 million and 16.5 million shares at October 1, 2022 and January 1, 2022, respectively(1,169.1)(767.7)
Additional paid-in capital775.0752.5
Accumulated other comprehensive loss(26.9)(5.5)
Retained earnings1,673.51,570.9
Total stockholders’ equity1,252.61,550.3
Total liabilities and stockholders’ equity3,056.41,887.0
Customer relationships  
Current assets  
Intangible assets, net204.515.3
Acquired technologies  
Current assets  
Intangible assets, net163.919.7
Other intangible assets, net  
Current assets  
Intangible assets, net$ 78.2$ 37.5